157 related articles for article (PubMed ID: 35307409)
21. Evidence for a role of mixed lineage kinases in neuronal apoptosis.
Mota M; Reeder M; Chernoff J; Bazenet CE
J Neurosci; 2001 Jul; 21(14):4949-57. PubMed ID: 11438570
[TBL] [Abstract][Full Text] [Related]
22. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
Hartkamp J; Troppmair J; Rapp UR
Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
[TBL] [Abstract][Full Text] [Related]
23. Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells.
Hong HY; Kim BC
Biochem Biophys Res Commun; 2007 Oct; 362(2):307-12. PubMed ID: 17707342
[TBL] [Abstract][Full Text] [Related]
24. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
25. Activity of the heat shock protein 90 inhibitor ganetespib in melanoma.
Wu X; Marmarelis ME; Hodi FS
PLoS One; 2013; 8(2):e56134. PubMed ID: 23418523
[TBL] [Abstract][Full Text] [Related]
26. Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.
Zhan Y; Modi N; Stewart AM; Hieronimus RI; Liu J; Gutmann DH; Chadee DN
Oncogene; 2011 Feb; 30(7):781-9. PubMed ID: 20890305
[TBL] [Abstract][Full Text] [Related]
27. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
Jain A; Tripathi R; Turpin CP; Wang C; Plattner R
Oncogene; 2017 Aug; 36(32):4585-4596. PubMed ID: 28368422
[TBL] [Abstract][Full Text] [Related]
28. E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis.
Montagnani V; Maresca L; Apollo A; Pepe S; Carr RM; Fernandez-Zapico ME; Stecca B
J Biol Chem; 2020 Nov; 295(47):16058-16071. PubMed ID: 32938713
[TBL] [Abstract][Full Text] [Related]
29. Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
Chen G; McQuade JL; Panka DJ; Hudgens CW; Amin-Mansour A; Mu XJ; Bahl S; Jané-Valbuena J; Wani KM; Reuben A; Creasy CA; Jiang H; Cooper ZA; Roszik J; Bassett RL; Joon AY; Simpson LM; Mouton RD; Glitza IC; Patel SP; Hwu WJ; Amaria RN; Diab A; Hwu P; Lazar AJ; Wargo JA; Garraway LA; Tetzlaff MT; Sullivan RJ; Kim KB; Davies MA
JAMA Oncol; 2016 Aug; 2(8):1056-64. PubMed ID: 27124486
[TBL] [Abstract][Full Text] [Related]
30. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
31. Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma.
Leung GP; Feng T; Sigoillot FD; Geyer FC; Shirley MD; Ruddy DA; Rakiec DP; Freeman AK; Engelman JA; Jaskelioff M; Stuart DD
Mol Cancer Res; 2019 Jan; 17(1):199-211. PubMed ID: 30201825
[TBL] [Abstract][Full Text] [Related]
32. Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells.
Datar I; Kalpana G; Choi J; Basuroy T; Trumbly R; Chaitanya Arudra SK; McPhee MD; de la Serna I; Yeung KC
PLoS One; 2019; 14(4):e0204387. PubMed ID: 30995246
[TBL] [Abstract][Full Text] [Related]
33. Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma.
Zhou B; Ritt DA; Morrison DK; Der CJ; Cox AD
J Biol Chem; 2016 Aug; 291(34):17804-15. PubMed ID: 27226552
[TBL] [Abstract][Full Text] [Related]
34. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex.
Figueroa C; Tarras S; Taylor J; Vojtek AB
J Biol Chem; 2003 Nov; 278(48):47922-7. PubMed ID: 14504284
[TBL] [Abstract][Full Text] [Related]
35. MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b.
Zhang J; Lu L; Xiong Y; Qin W; Zhang Y; Qian Y; Jiang H; Liu W
Clin Exp Dermatol; 2014 Apr; 39(3):376-84. PubMed ID: 24635082
[TBL] [Abstract][Full Text] [Related]
36. EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.
Misek SA; Chen J; Schroeder L; Rattanasinchai C; Sample A; Sarkaria JN; Gallo KA
Mol Cancer Res; 2017 Aug; 15(8):1085-1095. PubMed ID: 28487380
[TBL] [Abstract][Full Text] [Related]
37. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
Paraiso KH; Haarberg HE; Wood E; Rebecca VW; Chen YA; Xiang Y; Ribas A; Lo RS; Weber JS; Sondak VK; John JK; Sarnaik AA; Koomen JM; Smalley KS
Clin Cancer Res; 2012 May; 18(9):2502-14. PubMed ID: 22351686
[TBL] [Abstract][Full Text] [Related]
38. The potential role of HO-1 in regulating the MLK3-MKK7-JNK3 module scaffolded by JIP1 during cerebral ischemia/reperfusion in rats.
Song YJ; Dai CX; Li M; Cui MM; Ding X; Zhao XF; Wang CL; Li ZL; Guo MY; Fu YY; Wen XR; Qi DS; Wang YL
Behav Brain Res; 2019 Feb; 359():528-535. PubMed ID: 30412737
[TBL] [Abstract][Full Text] [Related]
39. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.
Kyula JN; Khan AA; Mansfield D; Karapanagiotou EM; McLaughlin M; Roulstone V; Zaidi S; Pencavel T; Touchefeu Y; Seth R; Chen NG; Yu YA; Zhang Q; Melcher AA; Vile RG; Pandha HS; Ajaz M; Szalay AA; Harrington KJ
Oncogene; 2014 Mar; 33(13):1700-12. PubMed ID: 23624923
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival.
Barthwal MK; Sathyanarayana P; Kundu CN; Rana B; Pradeep A; Sharma C; Woodgett JR; Rana A
J Biol Chem; 2003 Feb; 278(6):3897-902. PubMed ID: 12458207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
